I.B.N. Savio owns a broad portfolio of pharmaceutical and, more generally, healthcare products, which it promotes directly through its Savio Pharma Italia division or leases to Group companies or third parties for marketing both domestically and internationally. It also handles the entire distribution of its products throughout Italy, working with highly qualified companies specialized in these activities.
- Diabetological
-
ANDAMANES - Sitagliptin hydrochloride monohydrate
- Endocrine-metabolic
-
AGEMO - POLYENOIC OMEGAS - Class A - RR - Note 13
Respiratory
-
ALMEIDA - Salbutamol + ipratropium bromide - Class A - RR
Anti-infective
-
ALVAND - Levofloxacin - Class A - RR
-
AMOCLA - Amoxicillin + clavulanic acid - Class A - RR
Musculoskeletal
-

ANNISTER
ANNISTER - Cholecalciferol - Class A (RR) - note 96
-

ANNOVA
ANNOVA - Cholecalciferol - Class A (RR) - note 96
Cardiovascular
-
APONIL - Lacidipine - Class A - RR